Benzinga | Nov 5, 2020 04:08PM EST

ZIOPHARM Oncology Q3 EPS $(0.10) Misses $(0.09) Estimate

ZIOPHARM Oncology (NASDAQ:ZIOP) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.09) by 11.11 percent. This is a 25 percent decrease over losses of $(0.08) per share from the same period last year.